Best Telehealth Clinics in New Mexico (2026)

New Mexico's telehealth framework is codified at NMSA 1978, Chapter 24, Article 25 (the New Mexico Telehealth Act, sections 24-25-1 through 24-25-5). Controlled substance prescribing via telehealth requires synchronous audio/video communication. The prescriber must have had an in-person encounter with the patient within the prior 12 months and must establish a legitimate medical purpose for the prescription.

The 12-month in-person requirement is a state-level restriction that goes beyond what the federal DEA flexibility extension permits. Telehealth-only platforms cannot prescribe testosterone or other controlled substances to New Mexico patients without arranging an in-person evaluation within the prior year.

New Mexico passed IMLC legislation, but implementation has been delayed. The state is not yet an operationally active IMLC member as of April 2026. Providers must obtain a standard New Mexico medical license, which is a slower process than IMLC-expedited licensure.

New Mexico is a full practice authority state for nurse practitioners. NPs can prescribe independently without physician oversight, including controlled substances. This helps offset some of the access limitations created by the in-person requirement and pending IMLC status.

New Mexico Medicaid does not cover GLP-1 receptor agonists for obesity. SB 193 (proposed 2025) sought to expand coverage but has not been enacted. Coverage remains limited to diabetes indications.

New Mexico uses a gross receipts tax rather than a traditional sales tax. Prescription drugs are exempt from the gross receipts tax.

New Mexico has 2.1 million residents. Provider availability is moderate, limited by the 12-month in-person requirement for controlled substances and the pending IMLC status.

All-50-state providers like Maximus ($100/mo) and Hone Health ($25/mo) list New Mexico. TRT Nation ($99/mo, 45 states) includes NM. These platforms must coordinate in-person evaluations to comply with the 12-month requirement. BraverX ($129/mo), PeterMD ($99/mo), and DudeMeds ($77/mo) generally serve NM.

GLP-1 availability is unrestricted since GLP-1s are not controlled substances. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, and Mochi Health serve New Mexico. No Medicaid GLP-1 obesity coverage.

All HRT, hair loss, and ED providers with national coverage serve New Mexico for non-controlled medications.

TRT pricing from available providers: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year). The in-person visit requirement adds $150 to $400 in indirect costs.

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. New Mexico Medicaid does not cover GLP-1s for obesity.

Prescription drugs are exempt from New Mexico's gross receipts tax. The state has a progressive income tax with rates up to 5.9%.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.

TRT (testosterone replacement therapy)

New Mexico requires an in-person encounter within the prior 12 months for controlled substance prescribing via telehealth. Synchronous audio/video required. Full NP practice authority supports provider availability. IMLC implementation pending. Both compounded and FDA-approved testosterone are available.

GLP-1 weight loss

No state-specific GLP-1 restrictions. The in-person requirement does not apply to non-controlled substances. Federal FDA compounding rules apply. No Medicaid obesity coverage.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in New Mexico. No additional state restrictions apply for non-controlled HRT.

Hair loss

Hair loss treatment follows standard federal prescribing rules in New Mexico. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in New Mexico. No additional state restrictions apply.

Peptides

Controlled peptides are subject to the 12-month in-person requirement. Non-controlled peptides follow standard federal rules.